Follow
Anders Boss
Anders Boss
AVP Lilly
Verified email at lilly.com
Title
Cited by
Cited by
Year
Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial
J Rosenstock, DL Lorber, L Gnudi, CP Howard, DW Bilheimer, PC Chang, ...
The lancet 375 (9733), 2244-2253, 2010
2172010
In vivo load measurements on osseointegrated implants supporting fixed or removable prostheses: a comparative pilot study.
T Jemt, L Carlsson, A Boss, L Jörnéus
International Journal of Oral & Maxillofacial Implants 6 (4), 1991
2091991
Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans
V Lecoultre, L Egli, G Carrel, F Theytaz, R Kreis, P Schneiter, A Boss, ...
Obesity 21 (4), 782-785, 2013
1622013
Pharmacokinetics and linear exposure of AFRESA™ compared with the subcutaneous injection of regular human insulin
K Rave, E Potocka, AH Boss, M Marino, D Costello, R Chen
Diabetes, Obesity and Metabolism 11 (7), 715-720, 2009
1482009
Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial
P Raskin, S Heller, M Honka, PC Chang, AH Boss, PC Richardson, ...
Diabetes, Obesity and Metabolism 14 (2), 163-173, 2012
1162012
Coverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin
AH Boss, R Petrucci, D Lorber
Journal of diabetes science and technology 6 (4), 773-779, 2012
1142012
Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin
P Richardson, RA Baughman, E Potocka, AH Boss, R Petrucci
US Patent 8,119,593, 2012
992012
Superior control of blood glucose in diabetes treatment
WW Cheatham, AH Boss
US Patent 7,943,572, 2011
802011
Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content
AH Boss, R Petrucci, C Howard, A Mann
US Patent 8,258,095, 2012
78*2012
Technosphere® Insulin Technology
PC Richardson, AH Boss
Diabetes technology & therapeutics 9 (S1), S-65-S-72, 2007
762007
Method of reducing serum proinsulin levels in type 2 diabetics
W Cheatham, A Boss, A Pfuetzner
US Patent App. 11/032,278, 2005
752005
Randomized forced titration to different doses of Technosphere® insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 …
CJ Tack, V Christov, BE de Galan, KM Derwahl, G Klausmann, ...
Journal of diabetes science and technology 2 (1), 47-57, 2008
742008
Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents
J Rosenstock, R Bergenstal, RA DeFronzo, IB Hirsch, D Klonoff, AH Boss, ...
Diabetes Care 31 (11), 2177-2182, 2008
702008
Method of preserving the function of insulin-producing cells
AH Boss, WW Cheatham, DC Diamond
692007
Probability of achieving glycemic control with basal insulin in patients with type 2 diabetes in real-world practice in the USA
L Blonde, L Meneghini, XV Peng, A Boss, K Rhee, A Shaunik, S Kumar, ...
Diabetes Therapy 9, 1347-1358, 2018
652018
Anchoring member
L Jorneus, A Boss
US Patent 5,269,685, 1993
651993
Methods and compositions for minimizing accrual of inhalable insulin in the lungs
C Gelber, A Boss
632006
Inhaled Technosphere®/Insulin: Glucose elimination at the right time?
AH Boss, K Rave, WW Cheatham, T Heise
Diabetes 54, A109, 2005
632005
Inhaled Technosphere® insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes
K Rave, T Heise, L Heinemann, AH Boss
Journal of Diabetes Science and Technology 2 (2), 205-212, 2008
622008
Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus
H Zisser, L Jovanovic, K Markova, R Petrucci, A Boss, P Richardson, ...
Diabetes Technology & Therapeutics 14 (11), 997-1001, 2012
612012
The system can't perform the operation now. Try again later.
Articles 1–20